Vioxx
Merck pays $37m to settle Canadian Vioxx claims
January 23, 2012Sales and Marketing Canada, Merck, Vioxx
Merck will pay a maximum of C$37 million to settle all claims against its painkiller Vioxx in Canada. The settlement …
Merck pays $950 million to settle Vioxx charges
November 23, 2011Sales and Marketing Department of Justice, Merck, Vioxx, marketing violations, off label marketing
Merck will pay out $950 million and admit that it illegally marketed its painkiller Vioxx in the US. It will …
Drug regulators protect profits over patients, new study finds
May 11, 2011Research and Development Bad Science, Vioxx, regulatory affairs
Medicine regulators are protecting drug company profits over the welfare of patients by withholding trial data. That’s the verdict of …
Investors get green light to continue Merck lawsuit
April 29, 2010Merck, Vioxx
Investors suing Merck over ‘omissions and misstatements’ relating to its arthritis pain drug Vioxx will be allowed to continue with …
Merck to pay $4.9 billion to end Vioxx claims
November 15, 2007Sales and Marketing Vioxx, safety
Merck looks set to pay $4.9 billion in a settlement for the thousands of people claiming injury after taking its …
The weight of evidence – the stories that changed pharma in 2004
January 4, 2005Research and Development 2004, Vioxx, year in review
Ticking time bombsIn 2004, countries around the world faced up to some home truths about the health of their populations …
Lonngren lashes out at late warning
November 1, 2004EMA, EMEA, Lonngren, Vioxx
Thomas Lonngren, the head of Europe’s medicines regulator the EMEA has spoken out about Merck’s withdrawal of Vioxx, saying the …
Markets stunned as Merck withdraws blockbuster Vioxx
September 30, 2004Merck, Vioxx
Merck has taken the pharmaceutical world by surprise by announcing the immediate withdrawal of its blockbuster arthritis pain drug Vioxx …
Latest content
FibroFind appoints Lee Borthwick as CEO
